Renal Cancers Completed Phase 1 Trials for Aldesleukin (DB00041)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004890Biomed 101 and Interleukin-2 in Treating Patients With Kidney CancerTreatment
NCT00006022Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney CancerTreatment
NCT00418496Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic MelanomaTreatment